NCT03235050 A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT03191396 Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03182426 Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM) Status COMPLETED Phase PHASE1/PHASE2
NCT03172494 A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) Status COMPLETED Phase PHASE3
NCT03158805 Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated) Status COMPLETED Phase PHASE2
NCT03115099 A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT03087032 Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) Status RECRUITING Phase PHASE4
NCT03041792 Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects Status COMPLETED Phase PHASE1
NCT03018028 Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03011021 Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes Status UNKNOWN Phase PHASE1/PHASE2
NCT03011008 Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus Status UNKNOWN Phase PHASE4
NCT03010683 Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus Status COMPLETED Phase NA
NCT02973321 A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02967757 In-market Utilisation of Liraglutide Used for Weight Management in Europe Status COMPLETED Phase N/A
NCT02964247 LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors. Status COMPLETED Phase PHASE3
NCT02963935 Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting Status COMPLETED Phase PHASE3
NCT02960659 Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes Status COMPLETED Phase PHASE1/PHASE2